Grayslake, ILNCT07071532Now EnrollingIRB Ready

Bipolar Disorder Clinical Trial in Grayslake, IL

Access cutting-edge bipolar disorder treatment through this phase 1 clinical trial at a research site in Grayslake. Study-provided care at no cost to qualified participants.

Sponsored by AbbVie

Quick Self-Assessment

See if you qualify for this Grayslake location

Preparing your pre-screening questions…

Expert Care in Grayslake

Access bipolar disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related bipolar disorder treatment provided free

Apply for This Grayslake Location

Check if you qualify for this bipolar disorder clinical trial in Grayslake, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Grayslake

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Grayslake site if eligible
  4. 4Begin participation

About This Bipolar Disorder Study in Grayslake

This study will assess the adverse events and how oral ABBV-932 moves through the body when given with oral Itraconazole in adult participants with bipolar disorder.

Sponsor: AbbVie

Who Can Participate

Inclusion Criteria

Body Mass Index (BMI) ≥ 18.0 to ≤ 38.0 kg/m\^2 after rounding to the tenths decimal. BMI is calculated as weight in kg divided by the square of height measured in meters.
A condition of general good health, based upon the results of a medical history, physical examination, vital signs, laboratory profile, and a 12-lead ECG
Participants with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) primary diagnosis of bipolar I or II disorder as confirmed by the Mini International Neuropsychiatric Interview (MINI 7.0.2).

Exclusion Criteria

Participants with bipolar I or II disorder subject psychiatric history:
Clinical Global Impression-Severity (CGI-S) \> 4 at Screening or Baseline.
History of psychiatric hospitalization (inpatient or intensive outpatient) in the past 3 months prior to screening.
Major depressive or manic episode within the past 3 months prior to screening.
Lifetime history of schizophrenia spectrum or other psychotic disorders, dissociative disorders, or neurocognitive disorders.
History of moderate or severe substance use disorder (except nicotine) in the past 6 months prior to screening.
History of suicidal ideation within 1 year prior to study treatment administration as evidenced by answering "yes" to any question on the suicidal ideation portion of Columbia Suicide Severity Rating Scale (C-SSRS) at screening and/or history of suicidal behavior within 2 years prior to study treatment administration as evidenced by any "yes" answer to suicidal behavior questions on the C-SSRS.
History with any protocol prohibited medications, supplements, or herbal products, including any psychotropic drug or any drug with psychotropic activity (e.g., antipsychotic, antidepressant, anticonvulsant, mood stabilizer, herb, or over-the-counter medication with psychoactive potential) within 14 days or 5 half-lives of the medication (whichever is longer), prior to study treatment administration, with the exception of protocol-allowed medications listed in the protocol, including a total daily dose of ≤ 2 mg/day lorazepam.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Grayslake?

Yes, this clinical trial (NCT07071532) has an active research site in Grayslake, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Bipolar Disorder Treatment Options in Grayslake, IL

If you're searching for bipolar disorder treatment options in Grayslake, IL, this clinical trial (NCT07071532) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Grayslake research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced bipolar disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all bipolar disorder clinical trials near you to find additional studies recruiting in your area.

More Bipolar Disorder Trials in Grayslake, IL

See all bipolar disorder clinical trials recruiting in Grayslake — not just this study.

Browse Bipolar Disorder Trials in Grayslake →

Browse More Trials by Condition

Bipolar Disorder TrialsAll Conditions →

Ready to Join in Grayslake?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Grayslake, IL